AdamsMMcCroneS (2012) SRD5A1 genotype frequency differences in women with mild versus severe premenstrual symptoms. Iss Ment Health Nurs33: 101–108.
2.
DoornbosBFokkemaDSMolhoekM. (2009) Abrupt rather than gradual hormonal changes induce postpartum blues-like behavior in rats. Life Sci84: 69–74.
3.
GingnellMComascoEOrelandL (2010) Neuroticism-related personality traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene-linked polymorphism 5-HTTPLPR. Arch Womens Ment Health13: 417–423.
4.
LeschKPBengelDHeilsA (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science274: 1527–1531.
5.
MagnayJLEl-ShourbagyMFryerAA (2010) Analysis of the serotonin transporter promoter rs25531 polymorphism in premenstrual dysphoric disorder. Am J Obstet Gynecol203: 181.e1–5.
6.
MagnayJLIsmailKMKChapmanG (2006) Serotonin transporter, tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms in premenstrual dysphoric disorder. Am J Obstet Gynecol195: 1254–1259.
7.
MelkeJLandénMBagheiF (2001) Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet105: 458–463.
8.
MelkeJWestbergLLandénM (2003) Serotonin transporter gene polymorphisms and platelet [3H]paroxetine binding in premenstrual dysphoria. Psychoneuroendocrinology28: 446–458.
9.
NevatteTO’BrienPMBäckströmT; Consensus Group of the International Society for Premenstrual Disorders (2013) ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health16: 279–291.
10.
PinnaGCostaEGuidottiA (2009) SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol9: 24–30.
11.
UzunovDPCooperTBCostaE (1996) Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA93: 12599–12604.
